NCT00177619View on ClinicalTrials.gov

Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Prostatic Neoplasms
Interventions
DRUG

Alendronate

Trial Locations (1)

15213

University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Pittsburgh

OTHER

NCT00177619 - Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study) | Biotech Hunter | Biotech Hunter